Profile

Identity, professional record and current appointments.

Overview

Professional record at a glance

A concise summary of information supported by the cited public sources. Missing information is treated as unknown, not as a negative finding.

Current roles
22 current organizations shown on this profile
Board positions
22 supported by public sources, 0 supplied by the profile owner
Committee roles
Not establishedNo committee role is currently confirmed by the cited sources
Qualifications
Not establishedNo qualification is currently confirmed by the cited sources

Professional narrative

About

Alpha has not published a narrative summary because the current public source set is not sufficient.

Current roles

Appointments & responsibilities

Board appointments

Director

Moderna (NASDAQ: MRNA)

Jan 1, 2015 – Present

Independence: Independent

Source effective: 2026-03-16 · Observed: 2026-03-21T03:08:33.319514+00:00

confirmedView source

Governance

Board appointments, committee responsibilities and disclosed relationships.

Connections

Explore the roles, education and affiliations published in this record.

Lyell Immunopharma, Inc.

Open Lyell Immunopharma, Inc. profile →

Director at Lyell Immunopharma, Inc.

2021-01-01 → End not stated

current · source reported

Observed: 2026-09-13

Lyell Immunopharma…Lyell Immunopharma, Inc.ModernaModernaElizabeth Nabel

Dashed lines mark past roles. Select a connection to see its dates and sources.

Relationship map

Connected through the public record

Direct relationships from verified facts and published résumé records. Private connections are excluded.

Direct public links only

Only published affiliations are shown here. Private relationships require authorized access.

Experience

Career history, education, credentials and public contributions.

Published record

Featured coverage

Selected publications and public sources used to establish this profile. Inclusion records provenance; it is not an endorsement.

Source 1 · Sec ProxyPublic profile sourceSupports Director at Lyell Immunopharma, Inc. (NASDAQ: LYEL), Board membership.Open sourceSource 2 · Sec FilingModerna, Inc. director board sourceSupports Board membership, Director since, Board independence.Open source

Basis

Identifiers, sources, dates and record limitations.

Identifiers

Alpha ID
alpha:person:elizabeth-nabel
Record version
public-0

Sources

Sources and published information

Each item links to the public source used to support it. When sources disagree, the item is clearly marked for review.

Board independence · Source reportedIndependent director1 source
Verification
Source reported
Confidence
95%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Board membership · CorroboratedServes on the board of Lyell Immunopharma, Inc.Supported by 2 public records2 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
Board membership · Source reportedServes on the board of Moderna, Inc.Supported by 2 public records1 source
Verification
Source reported
Confidence
95%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

View all sources3 records
  1. https://www.sec.gov/Archives/edgar/data/1806952/000114036126016686/ny20068007x1_def14a.htm

    Sec Proxy · Tier not stated · Reviewed Apr 24, 2026

    Supports: Director at Lyell Immunopharma, Inc. (NASDAQ: LYEL) · Board membership

  2. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

    Supports: Board membership · Director since · Board independence

  3. https://www.sec.gov/Archives/edgar/data/1682852/000130817926000081/mrna-20260316.htm

    Sec Proxy · Tier not stated · Reviewed Mar 21, 2026

    Supports: Director at Moderna (NASDAQ: MRNA)